Elevate Impact, Inc.

What Elevate Impact, Inc. does

Elevate Impact, Inc. is a healthcare technology and services company founded in 2022 and headquartered in Arlington, Massachusetts. The company operates an AI-powered collaborative platform connecting patient advocacy organizations, clinicians, researchers, social workers, CROs, and industry partners into a unified ecosystem, with an initial focus on the global sickle cell disease community and an explicit roadmap to expand across rare and chronic diseases. Its core technology stack is built around three pillars: the Elevate Impact Collaborative Platform itself (a verified-membership network with passwordless, domain-based organizational identity and real-time analytics dashboards), the Access, Readiness, Conversion (ARC) Framework that structures trust-driven clinical trial enrollment, and a Trust as a Service (TaaS) methodology that converts community relationships into measurable engagement outcomes. AI capabilities are positioned across knowledge retrieval, process automation, and recommendation, drawing on text, structured, and multimodal community data.

The company's revenue model is multi-modal but performance-tilted: pharma and CRO partners are charged transaction fees only on successful clinical trial enrollments (Shared Success Model), with a portion of the success fee shared back to the advocates and providers who drove the enrollment. Secondary revenue streams include future enterprise licensing and white-label solutions for CROs and health systems (multi-year contracts), a freemium Founding Member window running June through September 2026 to seed the network, and HR/professional services covering people operations, leadership development, and fractional HR support for healthcare organizations. Go-to-market blends enterprise field sales (consultation booking, demo requests), community-led growth through verified invitation/domain-based membership, and event-driven demand generation via virtual workshops and cross-sector convenings.

Customer evidence to date consists of healthcare-provider engagements (Boston Medical Center for cultural responsiveness and implicit bias training; Lawrence General Hospital for board-level health equity upskilling), public-sector health equity workshops (Northern Bristol and Merrimack Valley Public Health Alliances), and patient-advocacy partnerships (Obi Ogbonnia Sickle Cell Foundation). The company is a certified Minority Business Enterprise and Supplier Diversity Office certified partner, positioning it to capture pharma supplier diversity and FDA diversity-action-plan spend. Headcount stands at approximately 10 employees with no disclosed institutional funding.

Name

Elevate Impact, Inc.

Legal name

Elevate Impact, Inc.

Website

https://elevateimpact.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Elevate Impact, Inc. is an AI-powered collaborative platform company serving the global sickle cell and rare-disease ecosystem, connecting patient advocates, clinicians, researchers, and pharma partners through its ARC Framework and Trust as a Service methodology to drive trust-based clinical trial enrollment.

Ownership category

akta.pro rank

Product category

Clinical Trial Enrollment Platform

NAICS

Computer Systems Design Services (541512), Social Assistance (624), Educational Support Services (611710)

SIC

Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)

akta.pro primary industry

Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• Clinical trial enrollment
• Patient advocacy platform
• Healthcare collaboration software
• Sickle cell disease ecosystem
• Trust-driven enrollment infrastructure

Headquarters

HQ city

Arlington

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Performance-Based Clinical Trial Enrollment: Pharma and CRO partners pay for results (enrollments), not promises. The ARC framework moves patients from awareness to enrollment through trusted community pathways. Revenue is earned when patients successfully enroll in clinical trials.
2. Shared Success Model: When a patient successfully enrolls, the pharma partner pays the enrollment success fee. A portion flows back to the advocates and providers who made it happen, creating shared success incentives across the ecosystem.
3. Platform Membership: Free access period from June-September 2026 for founding members with full access to people, projects, and tools. Future pricing will include enterprise licensing, white label solutions for CROs and health systems, and multi-disease expansion packages.
4. HR Consulting Services: People operations, leadership development, and fractional HR support services for healthcare organizations including benchmark assessments, program evaluations, strategy building, leadership coaching, and workshop facilitation.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Elevate Impact operates an AI-powered collaborative platform that connects patient advocacy organizations, clinicians, researchers, social workers, CROs, and industry partners into a coordinated ecosystem centered on sickle cell disease. The platform applies the ARC Framework (Access, Readiness, Conversion) and Trust as a Service (TaaS) methodology to translate community engagement into measurable clinical trial enrollments, with pharma and CRO partners paying for enrollment outcomes rather than outreach activity.

Product overview

Elevate Impact, Inc. operates as a unified platform-plus-services company offering an AI-powered collaborative platform for the global sickle cell ecosystem alongside structured frameworks and consulting services. The core offering is the Elevate Impact Collaborative Platform, which connects patient advocacy organizations, clinicians, researchers, and community organizations, powered by the ARC Framework (Access, Readiness, Conversion) for trust-driven clinical trial enrollment and Trust as a Service (TaaS) methodology. Supporting services include Virtual Workshops for leadership development, HR Services for fractional HR and organizational capacity, the Shared Success Model for enrollment-based revenue sharing, and Membership Access for verified network participation.

Differentiator

Problem solved

Functional benefit

Products and services

• Elevate Impact Collaborative Platform An AI-powered collaborative platform connecting patient advocacy organizations, clinicians, researchers, social workers, CROs, and community organizations to share knowledge, coordinate efforts, and drive collective impact for the sickle cell community. Powered by ecosystem intelligence that improves with every connection, with verified membership accessible through organizational email registration.
• ARC Framework (Access, Readiness, Conversion) A trust-driven enrollment infrastructure that helps pharma companies, CROs, and clinical trial sponsors accelerate patient engagement and participation. Provides structured, measurable pathways from community engagement to clinical trial enrollment through Access, Readiness, and Conversion phases.
• HR Services HR solutions including people operations leadership, fractional HR support, organizational capacity strengthening, leadership development, employee engagement, ERG development, and virtual workshops for HR leaders in healthcare organizations.
• Virtual Workshops Series Tailored workshop series addressing challenges facing leaders in nonprofits, biopharma, and hospital systems across patient advocacy, research, care, and community engagement. Topics include governance, storytelling, equity in partnerships, burnout prevention, and cross-sector collaboration.

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Three partnerships are on record, tiered minor and core.

• a2ruminorStrategic or Co-development PartnerArts integration in healthcare partnership focused on exploring creative approaches to healthcare challenges and patient engagement.
• VerbateminorStrategic or Co-development PartnerPartnership focused on elevating ERG (Employee Resource Group) leadership and supporting organizational diversity and inclusion initiatives.
• Obi Ogbonnia Sickle Cell Foundation (OOSCF)coreStrategic or Co-development PartnerSickle cell advocacy foundation connecting warriors to healthcare resources, digital skills training, and international advocacy opportunities. Represents the type of patient advocacy partnerships central to Elevate Impact's ecosystem.

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Mendel: AI-powered clinical trial matching platform using structured and unstructured patient data — directly comparable technology (AI ecosystem intelligence) and buyer (CROs/pharma sponsors) to Elevate Impact.
• Deep 6 AI: AI-driven clinical trial patient recruitment using EHR data — comparable technology approach and customer base (CROs and pharma sponsors accelerating enrollment).
• Antidote (Trial Library): Clinical trial patient recruitment and matching platform connecting patients to trials — directly comparable GTM motion (performance-based enrollment), although broader in therapeutic scope than Elevate Impact's sickle cell focus.

Broad incumbents

• Real Chemistry: Large healthcare marketing, communications, and patient engagement firm — a broad incumbent in healthcare ecosystem orchestration with overlapping CRO/pharma audiences.
• IQVIA (patient recruitment / site solutions): Largest clinical research services and patient recruitment provider globally — incumbent with deeper resources but more generalist positioning, which Elevate Impact's rare-disease/community-trust model differentiates against.
• Komodo Health: Healthcare analytics/AI platform for patient journey and clinical trial insights — comparable AI-driven patient intelligence layer and life sciences buyer base.
• Health Catalyst: Healthcare data and analytics platform serving health systems and life sciences — comparable health-IT infrastructure category and pharma/health system customer overlap.

Others

• National Organization for Rare Disorders (NORD): Major rare disease advocacy umbrella — adjacent non-profit ecosystem player with overlapping patient advocacy and rare disease communities central to Elevate Impact's network.

Emerging players

• Welltower / PatientPing (Appriss Health): Care coordination and real-time patient intelligence platform serving health systems and providers — comparable trust-based provider coordination value proposition.
• Findhelp (Aunt Bertha): Social services network connecting communities to health and social resources — comparable verified-network model linking patients/community organizations to resources.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@ElevateImpact
• LinkedInlinkedin.com/company/elevateimpact

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elevate Impact, Inc.